¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦6ȸ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2022-11-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦6ȸ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2022-11-19
±³À°ÀÏÀÚ : 2022-11-19
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç  
±³À°ÁÖÁ¦ : Á¦6ȸ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø  
´ã´çÀÚ : ¾ç½Â¿Ï
¿¬¶ôó : 02-3410-3035  
À̸ÞÀÏ : wanny.yang@samsung.com      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ±âŸ
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 09:10~09:40 Current status of CAR T-cell therapy in SMC  Won Seog Kim(SMC Korea) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 09:40~10:10 Approved and emerging CAR T-cell therapy in lymphoma  Anna Sureda(Blood Cell Barcelona Hematology Institute Spain) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 10:10~10:40 T-cell therapy in pediatric malignancy  Hee Young Ju(SMC Korea) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 11:00~11:30 CAR T-cell therapy in gastric cancer  Lin Shen(Peking University China) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 11:30~12:00 CAR T-cell therapy for solid tumors based on a new concept  Hiroshi Fujiwara(Mie University Japan) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 13:00~13:30 Practical issues of CAR T-cell therapy  Seok Jin Kim(SMC Korea) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 13:30~14:00 Advancing manufacturing process in CAR T-cell therapy  Bernd Eschgfaeller(Novartis Switzerland) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 14:00~14:30 Gene editing and CAR T-cell therapy  Dae Sik Kim(Sungkyunkwan University) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 14:50~15:20 Engineering Next-Generation CAR T-cell therapy for cancer therapy  Yvonne Chen(University of California Los Angeles USA) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 15:20~15:50 Next Generation CAR T-cell therapy against hematological malignancies  Kyungho Choi(SNU Korea) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 15:50~16:20 iPSC-derived CAR T-cell therapy  Maria Themeli(Cancer Center Amsterdam Netherlands) 
±³À°½Ã°£ 11-19 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 °­´ç 16:20~16:50 Towards Next-Generation T-cell Engineering for Cancer  Chan Hyuk Kim(KAIST Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦6ȸ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2022-11-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³âµµ Á¦8ȸ ¼ö¿ø½ÃÀÇ»çȸ Çмú´ëȸ : 2022-11-19
´ÙÀ½±Û 2022³âµµ ´ëÇѱÙÀüµµ∙Àü±âÁø´ÜÀÇÇÐȸ ¿öÅ©¼ó ¹× Ã߰迬¼ö°­Á : 2022-11-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
63 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦7ȸ Áö¿ª»çȸº´¿ø°ú ÇÔ²²ÇÏ´Â °¨¿°°ü¸® ½ÉÆ÷Áö¿ò : 2018-08-18 0 888 2018-07-28
62 ¼­¿ï 2018 ÇÏ°è ºÐÀÚÆó¾Ï¿¬±¸È¸ Àӻ󿬱¸ ¿öÅ©¼ó : 2018-08-18 0 543 2018-07-28
61 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ÃÊÀ½ÆÄ °Ë»ç ±Ç°í¾È ½ÉÆ÷Áö¾ö : 2018-08-18 0 776 2018-07-28
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,081 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 715 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 842 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 857 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,286 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 659 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 728 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 865 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,277 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 423 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 646 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷